The value of intermittent point-prevalence surveys of healthcare-associated infections for evaluating infection control interventions at Angkor Hospital for Children, Siem Reap, Cambodia. by Stoesser, N et al.
Stoesser, N; Emary, K; Soklin, S; Peng An, K; Sophal, S; Chhomrath,
S; Day, NP; Limmathurotsakul, D; Nget, P; Pangnarith, Y; Sona,
S; Kumar, V; Moore, CE; Chanpheaktra, N; Parry, CM (2013) The
value of intermittent point-prevalence surveys of healthcare-associated
infections for evaluating infection control interventions at Angkor
Hospital for Children, Siem Reap, Cambodia. Transactions of the
Royal Society of Tropical Medicine and Hygiene, 107 (4). pp. 248-
53. ISSN 0035-9203 DOI: 10.1093/trstmh/trt005
Downloaded from: http://researchonline.lshtm.ac.uk/2053998/
DOI: 10.1093/trstmh/trt005
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
The value of intermittent point-prevalence surveys of
healthcare-associated infections for evaluating infection control
interventions at Angkor Hospital for Children, Siem Reap, Cambodia
N Stoessera,b,c,*, K Emarya,b,c, S Soklina, K Peng Ana, S Sophala, S Chhomratha, NPJ Dayb,c, D Limmathurotsakulb,
P Ngeta, Y Pangnaritha, S Sonaa, V Kumara, CE Moorea,b,c, N Chanpheaktraa and CM Parrya,b,c
aAngkor Hospital for Children, Vithey Preah Sangreach Tep Vong & Um Chhay St., Sangkat Svay Dangkum Commune, Siem Reap,
Cambodia; bMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 3rd Floor, 60th Anniversary
Chalermprakiat Building, 420/6 Ratchawithi Rd., Ratchathewi District, Bangkok 10400, Thailand; cCentre for Clinical Vaccinology and
Tropical Medicine, University of Oxford, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK
*Corresponding author: Present address: John Radcliffe Hospital, Headley Way, Headington OX3 9DU, UK.
Tel: +44 1865 220856; Fax: +44 1865 222195; E-mail: nicole.stoesser@ndm.ox.ac.uk
Received 20 July 2012; revised 25 November 2012; accepted 5 December 2012
Background: There are limited data on the epidemiology of paediatric healthcare-associated infection (HCAI)
and infection control in low-income countries. We describe the value of intermittent point-prevalence
surveys for monitoring HCAI and evaluating infection control interventions in a Cambodian paediatric hospital.
Methods: Hospital-wide, point-prevalence surveys were performed monthly in 2011. Infection control interven-
tions introduced during this period included a hand hygiene programme and a ventilator-associated pneumonia
(VAP) care bundle.
Results: Overall HCAI prevalence was 13.8/100 patients at-risk, with a significant decline over time. The highest
HCAI rates (50%) were observed in critical care; the majority of HCAIs were respiratory (61%). Klebsiella
pneumoniae was most commonly isolated and antimicrobial resistance was widespread. Hand hygiene compli-
ance doubled to 51.6%, and total VAP cases/1000 patient-ventilator days fell from 30 to 10.
Conclusion: Rates of HCAIwere substantial in our institution, and antimicrobial resistance amajor concern. Point-
prevalence surveys are effective for HCAI surveillance, and in monitoring trends in response to infection control
interventions.
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Introduction
Healthcare-associated infection (HCAI) is a major threat to
patient safety, particularly in low-income countries.1 Here, the
capacity to implement infection control (IC) programmes is ham-
pered by a lack of resources, infrastructure, guidelines, surveil-
lance, and training.1,2 Current data suggests the prevalence of
HCAI in resource-limited settings is 15.5/100 patients, with the
highest infection densities in intensive care (47.9/1000 patient/
days); these are 3–4 times the figures in the USA.1 Data on
paediatric HCAIs from resource-limited countries are under-
represented in the literature,1 but associated mortality, morbidity
and healthcare costs are substantial.3
Cambodia is a resource-limited country in South-East Asia,
with some of the poorest regional health indicators.4 Recent
IC initiatives have been undertaken by the Ministry of Health in
conjunction with the WHO and private partners, and include a
National Infection Control Policy (2010) and Hand Hygiene Pro-
gramme (2011). However, HCAI surveillance and outcome data
are limited. Here we report our experience of using intermittent
point-prevalence surveys to monitor HCAI at a regional paediatric
hospital in Cambodia and their value in evaluating our efforts
at implementing IC.
Methods
Setting
Angkor Hospital for Children (AHC) is a charitably-funded,
50-bedded paediatric hospital in Siem Reap, Cambodia. It is the
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provincial paediatric referral centre, and also manages patients
from surrounding provinces (120 000 attendances/year;
2000–2500 admissions/year). Healthcare is free to children
,16 years of age. There is an intensive care unit (ICU; 4 isolation
rooms, 700–750admissions/year), andventilated/high-dependency
patients are also sometimes managed in the adjacent emergency
room (ER). Other facilities include surgical (SU), medical (in-patient
department/IPD) and ‘step-down’ care units (low acuity/LAU).
Healthcare-associated infection surveillance
An IC programmewas implemented in late 2010,with regular HCAI
surveillance from January 2011. During single-day, monthly cross-
sectional point-prevalence surveys, standardised data is collected
on all patients, detailing: location, age at admission, admission dur-
ation, diagnosis, comorbidities, current antimicrobials, presence/
site of HCAI and of invasive devices. HCAI diagnoses are based on
locally adapted, simplified versions of the CDC/NHSN definitions.5
An individual considered at-risk of HCAI was defined as a patient
with an admission duration of.48 hours.
Infection control interventions
Hand hygiene programme
Development of a hand hygiene (HH) programme commenced
late 2010 to early 2011, including an HH policy, perception
surveys of HH, and the introduction of an alcohol-based
hand-rub. Staff HH training was formalised from July 2011 and
incorporated into the induction process for new recruits. Baseline
HH compliance was audited in June 2011 (adapted from the
WHO ‘Save Lives: Clean Your Hands’ tools available at http://
www.who.int/gpsc/5may/tools/en) and two-monthly thereafter.
Compliance targets were set at 50% by January 2012, 75% by
July 2012, and .90% by July 2013.
Ventilator-associated pneumonia monitoring
and care bundle implementation
Ventilator-associated pneumonia (VAP) monitoring commenced
June 2011, with a care bundle phased in from July. This included:
intubation and suctioning protocols; elevation of bedheads; cir-
cuitry care; chlorhexidine mouthcare; and aggressive weaning
as tolerated.
Screening for carriage of Staphylococcus aureus
and multi-drug resistant-Gram negative bacilli
In December 2011, cross-sectional screening on a single day was
undertaken on all inpatients, using a nasal swab for S. aureus,
and a faecal sample for third-generation cephalosporin and/or
carbapenem resistance in Gram negative bacilli (GNB).
Nasal samples were cultured on mannitol salt agar; S. aureus
isolation was confirmed by Gram-stain and microscopy, catalase
testing and antigen detection (Staphaurex, Thermo Scientific,
Lenexa, KS, USA). Faecal specimens were diluted 1:10 with sterile
0.9% saline and 10 ml cultured aerobically on MacConkey agar
with cefpodoxime (10 mg) and imipenem (10 mg) discs.
Speciation of resistant organisms was undertaken using pheno-
typic tests. Confirmation of extended-spectrum beta-lactamase
(ESBL)-producing status for GNBwas performedwith combination
disc testing and susceptibility testing for all isolates was under-
taken in accordance with published guidelines.6
Statistical analysis
Statistical analysis was performed using Stata 11.1 (StataCorp,
College Station, TX, USA). Fisher’s exact and Kruskal-Wallis tests
were used for between-group comparisons of categorical and
continuous variables respectively. The Mantel–Haenszel x2-test
was used to analyse trends in HH compliance. Linear regression
was used to characterise crude trends in HCAI prevalence/anti-
biotic consumption. Multivariable logistic regression was used
to characterise risk factors for binary outcomes. A p-value of
,0.05 was considered statistically significant.
Results
Healthcare-associated infection surveillance data
During 2011 613 (median; range/month [53; 46–55]) patients
were surveyed: 47 on ICU (7.7%), 44 (7.2%) in the ER, 312 in the
IPD (50.9%), 98 (16.0%) in the SU and 112 (18.2%) on LAU.
Median (IQR; range) age at survey was 2.6 (0.5–8.7; 0–15.9)
years; this differed between units, with admissions to ICU/ER
being younger. Overall, 428/613 (69.8%) patients were at-risk of
HCAI; again this was significantly different between units (Table 1).
Overall antimicrobial usage and usage for commonly pre-
scribed antimicrobials is shown in Figure 1; ceftriaxone was
most frequently prescribed. Imipenem use increased significantly
from 2% to 29% by September (p¼ 0.04), and then declined.
Trends in consumption of other antibiotics were not significant.
In total, 356/428 (83.2%) at-risk children had a peripheral
intravenous catheter, 34 (7.9%) a urinary catheter, and 43
(10.0%) an endotracheal tube (ETT); 66 (15.4%) had other
medical devices, including 56 (13.1%) with nasogastric tubes,
four (0.9%) with chest drains, three (0.7%) with wound drains,
and one each (0.2%) with an external fracture fixation device,
peritoneal dialysis catheter, and orogastric tube.
Fifty-nine patients had evidence of an HCAI acquired at AHC
(13.8/100 patients at-risk); six others had been transferred with
HCAIs acquired elsewhere. A significant decline in HCAI prevalence
was noted, from a median of 15.8% in the first half of the year to
11.1% in the second (p¼ 0.01; Figure 2A). No significant trends
were observed by ward. The median (IQR) prevalence of HCAI in
patients at-risk was higher in the ICU/ER setting (50%; 25–67%)
versus the non-ICU/ER setting (3.1%; 0–12.9%) (p, 0.001). Uni-
variable logistic regression analyses were used to identify possible
risk factors for the presence of HCAI; on multivariable modelling,
four factors remained significant (Table 2).
Respiratory HCAIs predominated (22 VAPs, 14 hospital-
acquired pneumonias [HAPs]; 61% of all HCAIs), of which seven
had concomitant bloodstream infections and one a urinary
tract infection (UTI). Ten children had skin/soft tissue/wound
infections, one also with gastroenteritis. Four children had a
bacteraemia without an obvious source, one an isolated UTI,
one gastroenteritis, and six had systemic infection without a
clear focus or bacteraemia. There was one case of nosocomially-
acquired measles. Details of the HCAI case mix at each monthly
time-point are depicted in Figure 2B.
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Thirty-nine organisms deemed potentially clinically significant
were cultured from 30 specimens from 23 patients. Nine speci-
mens cultured mixed pathogens (seven respiratory site speci-
mens, one skin/wound sample, one blood culture). Klebsiella
pneumoniae was most commonly isolated (nine blood cultures,
five respiratory and one skin/wound specimen), followed by
Pseudomonas aeruginosa (one blood culture, five respiratory
and two skin/wound specimens). Two of three S. aureus isolated
(ETT, skin/wound) were MRSA and 11 of 13 (85%) K. pneumoniae
isolates with susceptibility data were extended-spectrum beta-
lactamase (ESBL) producers. There was one imipenem-resistant
P. aeruginosa isolate.
Ventilator-associated pneumonia surveillance data
Ventilator-associated pneumonia numbers decreased signifi-
cantly, from 30 to 10/1000 patient-ventilator days (p¼ 0.02).
Microbiological screening data
Of 54 children, 51 (94%) had nasal swabs and five (10%) were
colonised with S. aureus; one with MRSA (2% of patients
swabbed; 20% of carriers). The MRSA strain was resistant to
ciprofloxacin, gentamicin and clindamycin. The four methicillin-
susceptible S. aureus (MSSA) strains were resistant to penicillin;
one was additionally resistant to ciprofloxacin.
Of 54 patients, 29 (54%) submitted faecal samples, 25 (86%)
of whom were colonised with 31 cefpodoxime-resistant GNBs as
follows: Escherichia coli (n¼ 16), K. pneumoniae (9), Enterobacter
spp. (2), Edwardsiella tarda (2) and two organisms which
remained unspeciated. Sixteen (52%) of these strains were add-
itionally resistant to co-amoxiclav, ciprofloxacin and gentamicin.
No imipenem resistance was noted.
Hand hygiene programme results
The response rate for the baseline HH/HCAI perception survey
was 53.3%, and 50.5% a year later. At baseline, 80.7%
of respondents stated they routinely used hand-rub between
50–100% of the time; at re-survey this figure was 88.8%. The
commonest reason for non-compliance was skin irritation
perceived to be associated with hand-rubs. More than 75% of
respondents rated hospital education and accessibility of
hand-rub as ≥5 (scale from 0¼ ‘not effective’ to 7¼ ‘very effect-
ive’). About a third (34.0%) of respondents were unclear on the
institutional prevalence of HCAI compared with 23.9% at re-
survey (p¼ 0.09). More than half perceived the dangers
Figure 1. Percentage of patients on antibiotics by month (calculated as a
proportion of all patients surveyed) and on commonly prescribed
antibiotics (calculated as a proportion of all patients on antibiotics),
January–December 2011.
Table 1. Demographic and clinical details of patients surveyed by ward location
Ward Location (number of patients surveyed)
ICU (47) ER (44) IPD (312) SU (98) LAU (112) p value
Median age at survey in years (IQR) 0.2 (0.1–2.3) 0.2 (0–1.2) 1.5 (0.4–7.4) 4.5 (1.2–11.1) 6.2 (3.3–11.3) 0.0001
Number at riska of HCAI (% of patients
surveyed on ward)
45 (96) 25 (57) 192 (61.5) 87 (89) 79 (70.5) ,0.001
Median duration of admission in days (IQR) 17 (8–29) 4 (1–8.5) 3 (1.5–8) 8 (4–16) 4 (2–7) 0.0001
Number of patients surveyed with a
comorbidity (% of patients surveyed
on ward)
27 (57) 25 (57) 140 (44.9) 50 (51) 14 (12.5) ,0.001
Number of patients surveyed with a deviceb
in situ (% of patients surveyed on ward)
46 (98) 44 (100) 295 (94.5) 63 (64) 100 (89.3) ,0.001
Number of patients on antibiotics
(% of patients surveyed on ward)
38 (81) 41 (93) 248 (79.5) 64 (65) 92 (82.1) 0.002
ER: Emergency room; ICU: Intensive care unit; IPD: In-patient department; LAU: Low acuity; SU: Surgical unit.
aAt risk defined as admission duration .48 hours.
bThe definition of devices includes: peripheral intravenous catheter, urinary catheter, endotracheal tube, chest drain, wound drain,
nasogastric/orogastric tube, peritoneal dialysis catheter, external fixator.
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associated with HCAI as ‘low/very low’ at both time-points (54.8
and 58.3% respectively); 31.1% felt that HH had ‘low/very low’
efficacy in preventing HCAI, which only marginally dropped at
re-survey (26.4%).
The results of HH audits are presented in Figure 3. Overall
compliance doubled from 26.0% to 51.6% (p, 0.001).
Discussion
This paper describes the first Cambodian study of its kind, to our
knowledge. Several studies have investigated aspects of HCAI
and IC in the region, but these are mostly: from countries with
more advanced healthcare infrastructures and IC;7,8 singular
point-prevalence surveys;9 in the critical care setting only;10 or
undertaken with respect to specific infectious pathogens11 or
syndromes.12 Cambodia has only recently adopted national IC
guidelines, and in this respect is several years behind Thailand
and Vietnam.13,14
Perception of the risks of HCAI and associated outcomes were
relatively poor, despite on-going education. Self-reported HH
compliance was high, and contrasted with the observed rate at
audit (26.0–51.6%), a discordance described elsewhere.15
A third of staff erroneously felt HH was ineffective in preventing
HCAI. The lack of improvement in understanding at the repeat
survey was disappointing and may have been partly related to
staff turnover, as well as to cultural perceptions of hospital
hygiene, including an emphasis on visual cleanliness.16
However, monitored HH compliance has doubled, and is in line
with institutional targets. Future interventions to achieve the
.90% compliance target by July 2013 include improving
signage reminding staff/carers of the importance of HH, and
having a dedicated staff member policing HH on a daily basis.
We are also discussing the possibility of encouraging patient
carers to remind staff to clean their hands, although the cultural
barriers in overcoming the status of healthcare professionals
may be too substantial at present.
The prevalence of HCAI (13.8%) in our institution and
critical care setting (50.0%) is within the range observed in
other resource-limited countries.1 Respiratory HCAIs are most
common (61.0% of HCAIs), and the decline in overall HCAI preva-
lence was mirrored by that of VAP prevalence. Independent risk
factors for HCAI in our institution are similar to those else-
where.17 Attempts to mitigate risk have included implementing
antimicrobial and ventilation guidelines.
The epidemiology of HCAI at our institution may reflect the
current lack of central venous or arterial vascular devices, and
low rates of urinary catheterisation (7.0%) in contrast to those
in hospitalised adults.18 Rates of wound infection on the surgical
unit (used here as a proxy for surgical site infection) are relatively
low (2.3/100 at risk patients) in comparison to other published
data,1,3 which may relate to setting, case-mix and/or underlying
co-morbidities. We are currently switching to antisepsis with
alcohol-based chlorhexidine as opposed to aqueous iodine,
and will be introducing specific surgical site infection-based
surveillance.
Likely microbiological pathogens were isolated from clinical
samples in 39.0% of cases, and were mostly Gram-negative
species, as observed in several Asian countries.1 Interestingly,
K. pneumoniae, and not P. aeruginosa or Acinetobacter spp.,
was most commonly isolated. The majority of K. pneumoniae
were multi-drug resistant, susceptible only to carbapenems, co-
listin and variably to chloramphenicol. Imipenem is available but
expensive, and the global spread of carbapenem resistance is of
concern. The transient increase in imipenem usage observed
during the study period may have been in response to an
increased awareness of the high prevalence of ESBL-associated
infections, and peak use coincided with a cluster of cases of
ESBL-producing K. pneumoniae bloodstream infections, which
may have influenced prescribing patterns.
There are limited data on S. aureus carriage in hospitalised
children in Asia, with most studies undertaken in healthy and/
or community-based children. Prevalence ranges from 6.0–
26.0% for MSSA and 2.7–12.0% for MRSA,19,20 and is consistent
with our findings, albeit with small numbers. There were ex-
tremely high rates of faecal carriage of third-generation
cephalosporin-resistant GNB (86.0%), but isolation of these
patients to limit transmission is not feasible given the lack of
available facilities to do so. In addition, although we have
Figure 2. (A) Patients with healthcare associated infections (HCAI) as a
proportion of those at-risk at each monthly surveillance time-point,
January–December 2011. (B) Healthcare associated infection case mix
observed at each monthly time-point. The total number of patients
at-risk at each monthly time-point is expressed above each bar;
hospital-acquired pneumonias (HAP); urinary tract infection (UTI);
ventilator-associated pneumonia (VAP); skin/soft tissue infection (SSTI).
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made no assessment of carriage in the community, high rates of
ESBL carriage (29–51% of healthy community populations) have
been reported in Thailand,21 suggesting that these organisms are
probably widely disseminated in both hospital and community
settings in the region. The selection pressure for these organisms
exerted by nosocomial antibiotic use in our institution is substan-
tial, with 40–60% of patients on ceftriaxone at any time-point.
Limitations
There are several limitations to this survey. The numbers in our
study were small and we collected a restricted set of epidemio-
logical data. Serial point-prevalence monitoring is not as compre-
hensive as longitudinal surveillance; however, it is recognised as
an acceptable surveillance method in the context of resource/
staffing constraints,22 and has been shown to be an acceptable
approach in the monitoring of paediatric HCAI elsewehere.17,23
Criticisms of the point-prevalence methodology include the in-
ability to capture outbreaks of HCAI occurring between surveil-
lance time-points, and the possibility that there may have
been important demographic differences in the cohorts of chil-
dren surveyed which were not identified as a result of the
limited dataset collected, and therefore not controlled for in
the risk factor analyses. In addition, we were not able to
capture specific outcomes in relation to HCAI.
Our IC programme is hospital-wide, which meant that we
were unable to make controlled comparisons assessing the
impact of infection control interventions; in addition, it was not
possible to determine the efficacy of individual interventions
given the similar timeframes of introduction. There were no
policy changes in waste management, cleaning (undertaken in
accordance with Cambodian National Infection Control
Guidelines)24 or antibiotic prescribing during the study period,
but infection control and HCAI were highlighted as issues of im-
portance in meetings and on noticeboards. We were not able to
make an assessment of external factors, such as seasonality,
which may have influenced the epidemiology of HCAI.25
Finally, microbiological techniques may not determine the
true causative pathogens – especially for respiratory and skin/
soft tissue/wound infections.
Conclusions
Despite the limitations, we have broadly defined issues relevant
to HCAI in a Cambodian regional paediatric hospital including
Table 2. Univariable and multivariablea analysis of risk factors for the presence of HCAI in patients at-risk of HCAI
Univariable analysis Multivariable analysis
Factor Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Age (per increase of one year) 0.90 (0.84–0.97) 0.004 0.91 (0.84–0.98) 0.01
Duration of admission (per increase of one day) 1.04 (1.02–1.06) ,0.001 1.05 (1.03–1.08) ,0.001
Current antibiotic therapy 8.87 (2.12–37.07) 0.003 22.34 (3.84–129.95) 0.001
At least one chronic comorbidity 2.32 (1.11–3.41) 0.02 a NS
Intravenous catheter 6.65 (1.58–27.89) 0.01 a NS
Urine catheter 3.53 (1.62–7.71) 0.002 a NS
Endotracheal tube 11.5 (5.75–22.99) ,0.001 6.47 (2.92–14.30) ,0.001
Ward location
ICU 7.1 (2.78–18.14) ,0.001 a NS
ER 6.97 (2.38–20.45) ,0.001 a NS
IPD 0.86 (0.36–2.09) NS a NS
SU 0.21 (0.04–1.02) NS a NS
ER: Emergency room; ICU: Intensive care unit; IPD: In-patient department; NS: Not significant; SU: Surgical unit.
aIndependent risk factors for the presence of HCAI were identified using multivariable logistic regression analysis of all statistically significant
(p, 0.05) univariable risk factors with backwards elimination (exit p-value¼ 0.05); odds ratios for non-significant risk factors are therefore
not calculated.
Figure 3. Hand hygiene audit results, June–December 2011.
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perceptions related to HH, HCAI surveillance and risk factors for
HCAI, and antimicrobial susceptibility in clinical and carried
organisms, and correlated these with various IC interventions.
In particular, point-prevalence surveys have been a feasible
means through which we have been able to monitor trends in re-
sponse to the introduction of IC efforts, and could be deployed in
similar resource-restricted settings. This has been important in
highlighting local issues for concern, such as antimicrobial resist-
ance, in defining areas for intervention, and in contributing to the
body of knowledge on the subject from a country with minimal
currently published data.
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